The Experts in Animal Health

Brakke Consulting’s
Animal Health News & Notes for October 25, 2019
Copyright © Brakke Consulting

Editor: Lynn Fondon DVM MBA


Brakke Consulting news
New study – Pet Health Products: Changing Channels

Earnings News

Orion Animal Health
PetMed Express

Other News 

Alvetra & Werfft
Antech Diagnostics
Brilliant Biopharma
CZ Vaccines
Mars Petcare
Pathway Vet Alliance
Pegasus Laboratories
PRN Pharmacal
Spectrum Veterinary
Tyson Fresh Meats


Are pet product sales at an inflection point?

A new report from Brakke Consulting measures and characterizes the most dynamic changes taking place in the marketing of pet products – the emergence of new channels and the changing purchasing behaviors of pet owners, especially as it relates to products traditionally purchased at the veterinary clinic.

Pet Health Products: Changing Channels will be based on two national, representative studies: one, pet owners, the other veterinarians.  The data from these surveys will be compared to data from previous Brakke studies in these areas to highlight trends.

This timely new report will provide marketers and investors key insights to help:

  • Focus resources in the most productive areas
  • Build more effective defense strategies in key channels
  • Recalibrate channel strategies for principal products
  • Build innovative channel strategies for new products and categories
  • Design investment strategies based on “fishing where the fish are”

Pet Health Products, Changing Channels will be available by December 31, 2019.  Cost per report is $10,000.  Subscribers that order by Oct. 28, 2019 and pay in full earn a $500 early order discount.

For a prospectus or more information about this important study please contact us at or John Volk at


  • Nestlé reported results for the first nine months of 2019. Petcare sales were CHF 9.97 billion ($10.09 billion), an increase of 6.7% compared to the prior-year period. (Petfood Industry)
  • Orion Animal Health reported results for the third quarter of 2019. Sales were EUR 18.4 million ($20.5 million), a decline of 4% compared to the third quarter of 2018. Orion largely attributed the growth to the timing of deliveries to partners. (Animal Pharm)
  • Parnell Pharmaceuticals reported results for the first half of 2019. Sales were Aus$11.8 million ($8.1 million), a 13% decline from the prior-year period. (Animal Pharm)
  • PetMed Express, Inc. announced its financial results for the second fiscal quarter ended September 30, 2019. Net sales were $70 million, a decrease of 2% from the prior-year quarter. Net income was $6.7 million, a 38% decrease compared to net income of $10.8 million for the quarter ended September 30, 2018. (company website)
  • zooplus, Europe’s leading online retailer of pet supplies, recorded sales of EUR 1.1 billion ($1.2 billion) in the first nine months of 2019, representing growth of 13% compared to the same period in the prior year. (GlobalPets)


  • IDEXX Laboratories announced that Jonathan Ayers is stepping down as Chairman and a member of the IDEXX management team, effective November 1, 2019. This decision follows Mr. Ayers’ previously announced medical leave of absence from IDEXX. The IDEXX Board of Directors has appointed Jonathan (Jay) Mazelsky, who has been serving as Interim President and Chief Executive Officer since June 28, 2019, as President and Chief Executive Officer, effective immediately. (company press release)
  • Pegasus Laboratories, Inc. d.b.a. PRN Pharmacal announced the availability of once-a-day PROIN ER (phenylpropanolamine hydrochloride extended-release tablets) in November 2019. FDA-approved as a treatment for urethral sphincter mechanism incontinence, PROIN ER features a unique, patented extended-release technology. (company press release)
  • Alivira announced it has filed its 18th Veterinary Master file in the US, for robenacoxib API. (company announcement)
  • Parnell Pharmaceuticals announced it has entered a technology transfer agreement with an unnamed large multinational organization for the manufacture of the first of three animal health products. The firm and its new partner will immediately start working together on one specific product and will move onto two additional products over the coming 12-18 months. The name of the partner and the products involved were undisclosed. (Animal Pharm)
  • Vetericyn announced the launch of ALL-IN, a life-stage dog supplement that provides nutrient absorption. (Pet Business)
  • Covetrus announced that Benjamin Shaw has stepped down as the company’s president and chief executive officer and will transition to a strategic advisor to the board. Benjamin Wolin, who currently serves as the company’s chair of the board, will assume the role of acting CEO and president. (Business Wire)
  • Nextmune announced it has agreed to acquire the US veterinary business activities known as ACTT from ALK. ALK’s veterinary line of in-vitro testing and immunotherapy treatment sets, known as ACTT, and veterinary allergenic extracts, will transition to Nextmune’s wholly owned subsidiary Spectrum Veterinary, LLC as part of this transaction. Financial terms were not disclosed. (
  • Tyson Fresh Meats announced it will prohibit the use of ractopamine in the market hogs it buys from farmers beginning in February 2020. The move to expand export markets comes less than 2 weeks after JBS USA did the same. (Feed Strategy)
  • Pathway Vet Alliance acquired 15 practices in the third quarter of 2019, giving the veterinary hospital chain more than 200 locations in 33 states. (Todays Veterinary Business)
  • CANADA Antech Diagnostics, part of Mars Petcare, announced its acquisition of Quebec-based Biovet, a biotechnology company providing expertise in the field of diagnostics for animal health and agro-industry specialists in Canada and internationally. Financial terms were not disclosed. (PRNewswire)
  • EU CZ Vaccines announced the EU launch of B19 CZV Ocular, a new conjunctival brucellosis vaccine for cattle. (Animal Pharm)
  • AUSTRIA Belgium’s Inovet announced it has acquired all licenses and production rights held by Austrian firm Alvetra & Werfft, the veterinary division of human pharmaceuticals business Sanochemia. Alvetra & Werfft posted annual revenues of EUR 6.5 million ($7.2 million) in 2018. Financial terms of the transaction were not disclosed. (Animal Pharm)
  • INDIA Brilliant Biopharma announced plans to invest INR1.3 billion (US$18.2 million) to diversify into animal nutrition, as well as to broaden its present portfolio of vaccines for cattle, sheep, goats and dogs. (Feed Strategy)




  • US – PET FOOD The 16 pet food brands named most prominently in June 2019 by the FDA in its investigation into cases of canine dilated cardiomyopathy (DCM) are now experiencing sales declines, according to data recently presented by Nielsen. Looking at the brands’ grain-free dry dog food sales from mid-July 2019 through the first week of October, in aggregate they decreased about 10%. At the same time, other dry dog food sales showed a slightly positive trend.  Nielsen data also showed that for those 16 brands, their overall pet food sales had also been affected. (Petfood Industry)
  • US – VETERINARY SCHOOLS The University of Arizona announced that the AVMA’s Council on Education sent the school a letter of reasonable assurance, which allows the UA to begin enrolling students in the state’s first public veterinary medicine college. The university will be eligible for a provisional accreditation once the first class of students is enrolled, and for a full accreditation once they graduate. (
  • US – VETERINARY SCHOOLS Long Island University’s College of Veterinary Medicine announced it has received a Letter of Reasonable Assurance from the American Veterinary Medical Association’s Council on Education (AVMA-COE). This enables LIU to commence accepting applications for students who will begin the Doctor of Veterinary Medicine (DVM) program in Fall 2020. At full enrollment, the veterinary school will serve 400 students, with 100 in each graduating class. (
  • KOREA An international research team led by Korean scientists has shown that the Korean Native Black Pig — known for its red, marbled, good-tasting meat — has a gene variant not found in western pig breeds that affects the fiber structure of the muscle tissue, giving the pig more slow muscle fibers. The results were recently published in the journal PLoS Genetics. (Feedstuffs)
  • UK – RIFT VALLEY FEVER RESEARCH Researchers at The Jenner Institute at the University of Oxford have demonstrated that the ChAdOx1 RVF vaccine is effective at protecting pregnant sheep and goats from Rift Valley fever (RVF) with a single dose. (Animal Pharm)


This week John Volk and I attended the 7th Annual AVMA Economic Summit, which was titled “Changing Behavior – Harnessing Innovation.”  This two-day event was a delight to attend, especially the new special topic sessions that dealt with behavioral economics, creativity and digital transformation.  We’d like to tip our hats to Matt Salois, Chief Economist and Veterinary Economics Division Director of the AVMA and his team for a great conference.

Data regarding the frequently discussed topics of the demographics of veterinarians, veterinary education, student debt levels, the market for veterinarians and the market for veterinary services was provided for us.  But the focus this year was clearly less on assessing the economics of the past and more on how veterinarians can change the economics of the future.  Jason Lusk, from Purdue University, presented information on how we make decisions and how they are often biased – we have a lot to learn about how veterinarians and pet owners make decisions, especially decisions that have financial impact.  For me, the presentation by Allen Gannett, Chief Strategy Officer, Skyword, about how our belief that creativity is the realm of geniuses is wrong, was great.  His entertaining presentation showed us that this belief is wrong and that even scientific veterinarians can apply a few techniques to achieve success in any creative endeavor.

I’ll end with an idea that Matt opened the conference with – “Change doesn’t have to be big to be meaningful.”  Too often, we won’t change things, even though we know we need too, because they are too big, and we think we are not ready for big changes.  Certainly, making small changes, one step at a time is better than no change at all.  Thanks again to Matt and his team for a meaningful conference.

Bob Jones


Trouble viewing this newsletter?  You can view it online at

This electronic newsletter is the sole property of Brakke Consulting.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting.

For more information about Brakke Consulting’s services and syndicated studies, visit our website at
Brakke Consulting

806 Green Valley Rd
Suite 200
Greensboro, NC  27408

en_USEnglish (United States)